Form 13-F position report

MARKER THERAPEUTICS INC

Reported by MORGAN STANLEY

MRKR CUSIP 57055L206 Manager CIK 0000895421

Reported 0 shares, down 15 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 13 Through Q1 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 1377
2023-06-30 6014
2023-09-30 8808
2023-12-31 19790
2024-03-31 17372
2024-06-30 18506
2024-09-30 9611
2024-12-31 1113
2025-03-31 483
2025-06-30 613
2025-09-30 411
2025-12-31 22
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for MARKER THERAPEUTICS INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -15 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 15 -445 (-96.7%) < 0.01% $22 2026-02-13
Q3 2025 Added 460 +59 (14.7%) < 0.01% $411 2025-11-14
Q2 2025 Added 401 +8 (2.0%) < 0.01% $613 2025-08-15
Q1 2025 Added 393 +35 (9.8%) < 0.01% $483 2025-05-15
Q4 2024 Reduced 358 -3,050 (-89.5%) < 0.01% $1,113 2025-02-14
Q3 2024 Unchanged 3,408 0 (0.0%) < 0.01% $9,611 2024-11-14
Q2 2024 Reduced 3,408 -632 (-15.6%) < 0.01% $18,506 2024-08-14
Q1 2024 Added 4,040 +442 (12.3%) < 0.01% $17,372 2024-05-15
Q4 2023 Added 3,598 +1,658 (85.5%) < 0.01% $19,790 2024-02-13
Q3 2023 Unchanged 1,940 0 (0.0%) < 0.01% $8,808 2023-11-15
Q2 2023 Unchanged 1,940 0 (0.0%) < 0.01% $6,014 2023-08-14
Q1 2023 New 1,940 +1,940 (0.0%) < 0.01% $1,377 2023-05-15

Who else reported the position

42 managers reported MARKER THERAPEUTICS INC for Q1 2026.

Managers reporting MARKER THERAPEUTICS INC in Q1 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 1,625,678 0 0.12% $2,113,381 13 qtrs
Blue Owl Capital Holdings LP Unchanged 554,250 0 0.19% $720,525 6 qtrs
VANGUARD CAPITAL MANAGEMENT LLC New 389,319 +389,319 < 0.01% $506,115 1 qtr
Aisling Capital Management LP Unchanged 325,370 0 0.09% $422,981 12 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 175,294 +51,644 < 0.01% $227,882 13 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 160,910 +30,566 < 0.01% $209,206 13 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 93,121 -1,300 < 0.01% $121,057 13 qtrs
VANGUARD FIDUCIARY TRUST CO New 87,269 +87,269 < 0.01% $113,450 1 qtr
LPL Financial LLC Reduced 83,047 -200 < 0.01% $107,961 6 qtrs
XTX Topco Ltd Added 63,567 +5,526 < 0.01% $82,637 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2026
Filed
May 15, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.